Swine influenza is one of the major respiratory diseases in pigs, producing an economic impact in the swine industry. Clinical signs of swine influenza include high fever, lethargy, coughing, sneezing, nasal discharge, labored breathing, poor sperm quality, abortions, and reduced milk production. 2, 4, 6 Swine influenza virus (SIV) H1N1 was the subtype solely responsible for this impact in the United States until 1998, when SIV-H3N2 emerged. 1, 4, 7 This new strain caused both epizootic and enzootic swine influenza.
Currently, the hemagglutination inhibition (HI) assay is the serological method used most commonly in veterinary diagnostic laboratories for detecting swine serum antibodies against SIV. The HI assay performed in this study is conducted routinely at the Iowa State University's Veterinary Diagnostic Laboratory (ISU-VDL, Ames, IA) with the cutoff value of 1:40. Titers at 1:10-1:20 may be true positives but may also be due to nonspecific reactions because some of the known positive and negative samples collected from experimentally infected animals had the titer of 1:10-1:20 (data not shown). Hemagglutination inhibition is a time-consuming and labor-intensive immunoassay requiring serial dilution of serum samples, preparation of reagents, standardization of viruses, and manual reading of plates. 5 Recently, a commercial indirect enzyme-linked immunosorbent assay (ELISA) a became available for detecting swine antibodies against SIV-H1N1. This ELISA can test 92 serum samples per plate in less than 2 hours, and the reagents are ready to use except for the wash solution, which requires simple 1:10 dilution with distilled/deionized water. The ELISA requires only 1 serum dilution (1:40). Optical density in test wells is measured, and test results are calculated automatically using a commercial software. b A sample to positive (S/P) ratio of 0.4 or greater is considered positive.
The objective of this study was to compare the ELISA with the HI assay to assess the agreement between the tests using experimental and field-serum samples. All samples were tested on the SIV HI for H1N1 and H3N2 according to the standard protocol routinely performed at ISU-VDL. Swine influenza viruses used in the HI assay were prepared from isolates A/Swine/IA/73 (the standard virus provided by National Veterinary Services Laboratories, Ames, IA [NVSL] c to veterinary diagnostic laboratories for use in the H1N1 HI test) for H1N1 and A/Swine/IA/8548-1/98 (a virus isolated at ISU-VDL that is antigenically equivalent to the standard virus provided by NVSL c for use in the H3N2 HI test) for H3N2. Rooster and turkey red blood cells used for H1N1 and H3N2, respectively, were obtained from NVSL. c A commercial receptor-destroying enzyme d was used to remove nonspecific serum inhibitors when testing for H3N2 antibodies. The H1N1 ELISA was performed according to the manufacturer's instructions, a and the resulting optical densities were used to calculate the sample to positive ratio (S/P), providing either a positive or a negative designation using a commercial software. b To evaluate the ELISA in comparison with the HI * ELISA was performed according to the manufacturer's instruction. Hemagglutination inhibition was performed according to the routine procedure at ISU-VDL.
† Nine samples were collected 25 DPI from pigs experimentally infected with SIV A/SW/IA/40776/92. ‡ ELISA results were expressed as sample-positive (S/P) ratio, and Ն0.4 was considered as positive.
§ The numbers represent the HI titers expressed as the reciprocal dilution of serum samples. † The cutoff value for HI was 1:40. ‡ ELISA results were expressed as sample-positive (S/P) ratio, and Ն0.4 was considered as positive.
tests, the following groups of swine serum samples were used. Group 1 consisted of 96 sequential samples collected at 0, 7, 15, and 25 days postinfection (DPI) from 24 pigs (3 weeks old) experimentally infected with SIV A/SW/IA/40776/92 (an H1N1 field strain isolated at ISU-VDL). As shown in Table 1 , samples collected at 0 DPI were all negative by HI and ELISA.
Of 24 samples collected at 7 DPI, 3 were positive by HI, and all were negative by ELISA. The HI detected an additional positive pig at DPI 15 and 25, and the ELISA detected 1 positive pig at DPI 15 and 4 additional positive pigs at DPI 25. The ELISA results revealed that the serum samples collected between DPI 0 and DPI 25 did show an increase in the S/P ratios from 0 to 0.393, even though the values did not reach the established positive threshold (data not shown).
These results clearly showed that the current HI using the older strain of SIV (A/Swine/IA/73) and ELISA using the SIV antigens from a 1988 isolate were not able to detect antibody in all animals infected with the 1992 isolate. To confirm the presence of H1N1 antibodies in these serum samples, nine 25-DPI samples were tested by HI using the homologous virus (A/SW/ IA/40776/92), a 2001 H1N1 SIV isolate from NVSL, c and a 1999 H1N1 isolate currently used in a commercial vaccine. e As shown in Table 2 , all 9 samples were positive for antibody as detected by the homologous virus, the 2001 isolate, and the 1999 isolate, with average geometric mean titers of 169 (range 80-320), 133 (range 80-320), and 80 (range 40-160), respectively. Group 2 samples consisted of 780 field samples submitted without herd histories to ISU-VDL for routine SIV HI testing that were subsequently used to evaluate the ELISA in comparison with the HI. Swine influenza virus isolates used in the HI assays were H1N1 A/ Swine/IA/73 and H3N2 A/Swine/IA/8548-1/98. As shown in Table 3 , of 314 HI H1N1-positive samples, 291 were positive by ELISA. In contrast, of 466 HI H1N1-negative samples, 376 were negative by ELISA.
This comparison generated an overall agreement of 85.5% between these tests. These results suggest that if the HI is used as the ''gold standard,'' the ELISA would generate 7.3% false-negative results by missing 23 of 314 HI-positive samples. On the other hand, the ELISA would produce 19.3% false-positive results by detecting ''antibody'' in 90 of 466 HI-negative samples.
To evaluate cross-reactivity with antibody against H3N2 SIV in the H1N1 ELISA, 4 subgroups were defined from these 780 samples. Subgroup 1 consisted of 108 H1-positive and H3-negative samples, subgroup 2 contained 130 H1-negative and H3-positive samples, subgroup 3 contained 206 H1 and H3 positives, and subgroup 4 consisted of 336 H1 and H3 negatives. The results from Table 4 showed that of 108 samples that were H1N1 positive and H3N2 negative (subgroup 1) on the HI assay, 20 samples were ELISA negative. Of 130 samples that were H1N1 negative Table 4 .
† ELISA results were expressed as sample-positive (S/P) ratio, and Ն0.4 was considered as positive.
‡ The cutoff value for HI was 1:40. § % agreement ϭ (A ϩ D/A ϩ B ϩ C ϩ D) ϫ 100. and H3N2 positive (subgroup 2) by HI assay, 21 samples were ELISA positive. From the data generated from these groups of samples, there was 16-18.5% discrepancy between HI and ELISA, indicating some degree of cross-reaction between H1 and H3 by the ELISA, which has been claimed by the manufacturer. f The overall agreement was 82.8%. Of 206 samples that were both H1N1 positive and H3N2 positive (subgroup 3) by HI assay, only 3 were negative by ELISA ( Table 4 ). The discrepancy for this group of samples between HI and ELISA was 1.5%. When testing 336 samples for both H1-and H3-negative status by the HI assay, 69 samples were ELISA positive, which generated a 25.8% discrepancy (subgroup 4). The agreement between the HI and ELISA for these groups of samples was 86.7% ( Table 4 ). The 113 samples with discrepant results between the HI and ELISA were further evaluated by the HI using the SIV 1992 isolate. The HI results in comparison with the ELISA results are summarized in Table 5 . Of the 90 samples positive by ELISA, 83 were positive by the HI against the 1992 isolate, and of the 23 samples negative by ELISA, 21 were negative by the HI, which generated the total agreement of 92% between the 2 tests. These results provided clear indication that the virus (1988 isolate) used in the ELISA is more related to the virus isolated in 1992 than that isolated in 1973 in terms of the interaction with the antibodies.
Overall, the data presented in this study showed that the ELISA had 82.8-86.7% agreement with the HI for detecting swine influenza antibodies. However, because the viruses used in both the HI and the ELISA were not the same isolates and were relatively old (1973 and 1988 isolates, respectively), some degree of discrepancy may be expected between these assays and they may not detect antibodies against the current SIV isolates. The results presented in this study from both experimental and field samples clearly indicate that the SIVs used in the HI and ELISA need to be replaced with a new SIV isolate to improve the test accuracy.
In a primary viral infection, the first antibody to appear in the blood circulation is of the IgM class, and it disappears shortly after the IgG antibodies are developed. 5 The ELISA has been shown to detect IgG, including maternal antibodies at a very low level, but it detects IgM antibodies to a lesser degree. In contrast, the HI assay detects both IgM and IgG antibodies. The HI test can detect maternal antibodies but may not be as effective in monitoring declining maternal antibodies once the titers drop to levels (Ͻ1:40) that are more difficult to interpret because of possible nonspecific reactions that can interfere with the test. 3, 5 It is speculated that these may contribute to certain degrees of discrepancies in the results obtained with the two assays even though the Ig classes were not confirmed in these tests. c. National Veterinary Services Laboratories, Ames, IA. d. Biowhittaker, Walkersville, MD. e. Pfizer Animal Health, Groton, CT. f. IDEXX Laboratories, Inc., Westbrook, ME.
Keratinizing ameloblastoma in a 9-month-old llama (Lama glama)
Karyn E. Bird, 1 Jill E. Parker, Claire B. Andreasen, Barbara J. Watrous, Jerry R. Heidel Abstract. A 9-month-old male llama (Lama glama) was presented because of a rapidly growing mass on the right side of the face. Radiographs revealed a marked expansion of the right caudal face region with bone lysis involving the maxilla and the nasal, lacrimal, zygomatic, and palatine bones. Cytologically, the mass consisted of atypical round to polygonal cells with round nuclei and basophilic cytoplasms that formed acini and rows. Histologically, the mass consisted of anastomosing cords and sheets of neoplastic odontogenic epithelial cells embedded in a loose fibrovascular connective tissue. Single layers of peripheral, polarized, palisading, columnar epithelial cells were seen at the edges of some cords. Within the centers of the cords, epithelial cells showed rapid progression to keratin production. The histologic diagnosis was keratinizing ameloblastoma. Ameloblastomas are neoplasms of odontogenic epithelium that tend to be locally aggressive and can cause substantial destruction of bony structures. Because ameloblastomas do not tend to metastasize, they can be successfully treated by complete surgical excision, performed before extensive bony destruction occurs. Ameloblastoma, although expected to be rare, should be on the list of differential diagnoses for facial swelling in llamas.
A 9-month-old male llama weighing 78 kg (171 lb) was admitted to the Oregon State University Veterinary Teaching Hospital, Corvallis, Oregon, because of a rapidly enlarging mass on the right side of the face. The llama had been acquired 3 months earlier, and the owner had noticed the mass shortly after acquisition. Previous treatment consisted of lancing the swelling on the assumption that it was an abscess, which resulted in a bloody discharge and a nonhealing wound. The mass did not interfere with mastication and did not appear to be painful.
Except for the large mass on the right side of the face, no abnormalities were identified on physical ex- amination. A firm, centrally ulcerated, 10-cm-diameter, irregular, protruding mass covered the entire right maxilla and extended to the rostral and ventral borders of the orbit. Radiographs (Fig. 1) showed marked expansion of the right facial region, extending from the base of the orbit through the lacrimal region with lysis of the right maxilla and the nasal, lacrimal, zygomatic, and palatine bones. Fine-needle aspirate and core biopsy specimens were obtained. Aspirated blood-colored fluid and biopsied tissue samples were cultured. No aerobic or anaerobic organisms were grown.
The cytologic smear from the aspirate contained thick clusters of rounded cells (Fig. 2) . Thinner areas had round to polyhedral cells with eccentric, round nuclei and dark blue cytoplasm. These cells also formed acini and rows. Cell borders were often indistinct. Anisokaryosis and anisocytosis were minimal to moderate. Some cells had perinuclear clearing. Scattered keratinocytes undergoing keratinization were
